Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 104, Issue 6, Pages 813-821Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/bjophthalmol-2018-313396
Keywords
glaucoma; clinical trial
Categories
Funding
- Australian National Health and Medical Research Council (NHMRC) [1009844]
- NHMRC Research Fellowship [1045280]
- NHMRC Practitioner Fellowship [529915]
- NHMRC Early Career Fellowship [1072987]
- Dorothy Adele Edols Charitable Trust
Ask authors/readers for more resources
Background/Aims To determine if selective laser trabeculoplasty (SLT) is superior to topical medication as a first-line treatment for glaucoma on quality of life (QoL) and clinical outcomes. Methods In this international, longitudinal, multisite randomised controlled trial, treatment naive mild-to-moderate primary open angle or exfoliation glaucoma patients were randomised 1:1 to SLT or topical medication. Glaucoma-specific QoL (primary outcome) was measured using the Glaucoma Outcomes Assessment Tool (GOAT; 342 items, 12 domains). Secondary outcomes included rate of successful intraocular pressure (IOP) reduction (>25% reduction from baseline) and presence of ocular surface disease including conjunctival hyperaemia and eyelid erythema. Our intention-to-treat analysis was performed at months 12 and 24. Results Of 167 enrolled patients, 83 and 84 were randomised to SLT and topical medication, respectively; and 145 (n=75 SLT, n=70 medication) completed 24-month follow-up. While both treatment arms achieved significant within-group gains in GOAT outcomes at both endpoints, SLT patients reported a greater between-group improvement in 'social well-being' compared with medication patients (mean +/- SE=0.28 +/- 0.13; p=0.034) at 24 months. At month 24, the rate of successful IOP reduction was 18.6% (95% CI 3.0% to 34.3%, p=0.022) higher (absolute difference) in the medication compared with SLT group. More individuals in the medication group had conjunctival hyperaemia and eyelid erythema compared with SLT at 24 months. Conclusion Overall, we did not find evidence that SLT was superior to medication in improving glaucoma-specific QoL. While we found superior IOP reduction in the medication arm, eyelid erythema and conjunctival hyperaemia were more prevalent in these patients compared with the SLT group.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available